These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9844784)

  • 41. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE; Gülfe A; Saxne T; Geborek P
    Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
    Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serological markers in psoriatic arthritis: promising tools.
    Ramonda R; Modesti V; Ortolan A; Scanu A; Bassi N; Oliviero F; Punzi L
    Exp Biol Med (Maywood); 2013 Dec; 238(12):1431-6. PubMed ID: 24146263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: modulation of P-glycoprotein function.
    Diamanti AP; Rosado M; Germano V; Scarsella M; Giorda E; Podestà E; D'Amelio R; Carsetti R; Laganà B
    Clin Immunol; 2011 Jan; 138(1):9-13. PubMed ID: 21062675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis.
    Mori Y; Kuwahara Y; Chiba S; Itoi E
    Mod Rheumatol; 2015 May; 25(3):431-4. PubMed ID: 25295919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is soluble CD44 variant isoform 5 useful as a predicting factor and a parameter for long term observation in rheumatoid arthritis?
    Skoumal M; Kolarz G; Haberhauer G; Feyertag J; Wottawa A
    Ann Rheum Dis; 2002 Nov; 61(11):1036-7. PubMed ID: 12379536
    [No Abstract]   [Full Text] [Related]  

  • 47. T-helper 17 cells: the driving force of psoriasis and psoriatic arthritis.
    Yoo IS; Lee JH; Song ST; Kim JH; Lee HJ; Kang SW
    Int J Rheum Dis; 2012 Dec; 15(6):531-7. PubMed ID: 23253236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Serum Assay of Soluble CD44 Standard, CD44 Variant 5, and CD44 Variant 6 in Patients with Gastric Cancer.
    Yoo CH; Noh SH
    Cancer Res Treat; 2003 Feb; 35(1):3-8. PubMed ID: 26680908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review.
    Smolen JS; Schoels M; Aletaha D
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S48-50. PubMed ID: 26471734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
    Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
    Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low serum hyaluronan in psoriatic arthritis patients in comparison to rheumatoid arthritis patients.
    Partsch G; Leeb B; Stancikova M; Raffayova H; Eberl G; Hitzelhammer H; Smolen JS
    Clin Exp Rheumatol; 1996; 14(4):381-6. PubMed ID: 8871836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis.
    Foell D; Kane D; Bresnihan B; Vogl T; Nacken W; Sorg C; Fitzgerald O; Roth J
    Rheumatology (Oxford); 2003 Nov; 42(11):1383-9. PubMed ID: 12832707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis.
    Ross EL; D'Cruz D; Morrow WJ
    J Rheumatol; 2000 Oct; 27(10):2432-43. PubMed ID: 11036841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular endothelial growth factor in patients with psoriatic arthritis.
    Fink AM; Cauza E; Hassfeld W; Dunky A; Bayer PM; Jurecka W; Steiner A
    Clin Exp Rheumatol; 2007; 25(2):305-8. PubMed ID: 17543159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet reactivity and disease activity in subjects with psoriatic arthritis.
    Di Minno MN; Iervolino S; Peluso R; Scarpa R; Di Minno G
    J Rheumatol; 2012 Feb; 39(2):334-6. PubMed ID: 22174208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated platelet-monocyte complexes in patients with psoriatic arthritis.
    Pamuk GE; Nuri Pamuk O; Orüm H; Arican O; Turgut B; Demir M
    Platelets; 2009 Nov; 20(7):493-7. PubMed ID: 19852688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis.
    Eder L; Thavaneswaran A; Chandran V; Cook R; Gladman DD
    Ann Rheum Dis; 2015 Oct; 74(10):1830-5. PubMed ID: 24827532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-density lipoprotein cholesterol in patients with psoriatic arthritis.
    Skoczyñska AH; Turczyn B; Barancewicz-Losek M; Martynowicz H
    J Eur Acad Dermatol Venereol; 2003 May; 17(3):362-3. PubMed ID: 12702094
    [No Abstract]   [Full Text] [Related]  

  • 59. Normal values of laboratory tests in elderly onset psoriatic arthritis.
    Nava A
    Ann Rheum Dis; 2000 Mar; 59(3):239. PubMed ID: 10777420
    [No Abstract]   [Full Text] [Related]  

  • 60. [Lipomembranous panniculitis in psoriatic arthritis].
    Cornillier H; Martaille V; Maitre F; Estève E
    Ann Dermatol Venereol; 2017; 144(6-7):456-458. PubMed ID: 28259466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.